1
|
Archin N, Bar K, Burdo T, Caskey M, Chahroudi A, Farzan M, Ho YC, Jones R, Kearney M, Kuritzkes D, Margolis D, Martinez-Picado J, Okoye A, Salgado M, Stevenson M. Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA. J Virus Erad 2023; 9:100315. [PMID: 36911658 PMCID: PMC9996320 DOI: 10.1016/j.jve.2023.100315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
The International Workshop on HIV Persistence during Therapy provides a forum in which HIV/AIDS researchers gather to share the latest research findings related to viral reservoirs and cure. The Tenth Workshop, which was attended by over 400 delegates, extended over 4 days and comprised eight sessions covering topics from the basic science of viral persistence to therapeutic approaches to HIV cure. Furthermore, satellite sessions on the first day of the Conference featuring cure research endeavours being pursued by the Bill and Melinda Gates Foundation as well as those being coordinated under the National Institutes of Health Martin Delaney Collaboratory program, provided important updates on research advances being made in these initiatives. As with previous conferences, the International Workshop on HIV Persistence during Therapy is primarily abstract-driven with only one invited talk for each of the sessions. This format, therefore, increases the number of presentations from early-stage investigators. Furthermore, presentations by Community representatives illustrated approaches to creating cure research literacy with effective messaging for the Community. The following article offers a synopsis of the meeting sessions. Due to space constraints, some presentations may have only been briefly discussed. Nevertheless, the Workshop abstracts can be found online (https://www/sciencedirect.com/journal/journal-of-virus-eradication/vol/8/suppl/S).
Collapse
Affiliation(s)
- N. Archin
- Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, USA
| | - K.J. Bar
- Dept of Medicine, University of Pennsylvania, Philadelphia, USA
| | - T. Burdo
- Department of Microbiology, Immunology and Inflammation, Center for Neurovirology and Gene Editing, Temple University, Philadelphia, USA
| | - M. Caskey
- Rockefeller University, New York, USA
| | - A. Chahroudi
- Emory University, School of Medicine, Atlanta, USA
| | - M. Farzan
- Department of Immunology and Microbiology, UF Scripps Biomedical Research, Jupiter, USA
| | - Y.-C. Ho
- HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG), New Haven, USA
| | - R.B. Jones
- Dept of Medicine, Weill Cornell Medicine, New York, USA
| | - Mary Kearney
- HIV Dynamics and Replication Program, Host-Virus Interaction Branch, National Cancer Institute, National Institutes of Health, Frederick, USA
| | - D. Kuritzkes
- Harvard Medical School Infectious Disease, Boston, USA
| | | | | | - A. Okoye
- Oregon Health and Science University, USA
| | - M. Salgado
- IrsiCaixa Institute for AIDS Research, Badalona, Spain
| | | |
Collapse
|